Arovella Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Operating Revenue	0.14	0.02	0.41	0.3	0.26	Upgrade
Other Revenue	3.3	1.94	1.05	-	0.73	Upgrade
Revenue	3.44	1.95	1.45	0.3	0.99	Upgrade
Revenue Growth (YoY)	76.22%	34.20%	391.75%	-70.11%	-20.91%	Upgrade
Cost of Revenue	-	-	0.2	0.21	0.24	Upgrade
Gross Profit	3.44	1.95	1.25	0.09	0.75	Upgrade
Selling, General & Admin	2.21	1.36	1.5	1.32	1.31	Upgrade
Research & Development	6.52	6.74	3.98	2.6	0.71	Upgrade
Other Operating Expenses	1.65	1.64	2.7	2.63	2	Upgrade
Operating Expenses	11.34	10.83	9.88	7.69	4.7	Upgrade
Operating Income	-7.9	-8.88	-8.63	-7.6	-3.96	Upgrade
Interest Expense	-	-0.01	-0	-0.19	-0.03	Upgrade
Interest & Investment Income	0.39	0.14	0.03	0	0.01	Upgrade
Other Non Operating Income (Expenses)	-	-	-0.02	-0	-0.01	Upgrade
EBT Excluding Unusual Items	-7.51	-8.75	-8.62	-7.79	-3.98	Upgrade
Asset Writedown	-	-	-1.56	-0.83	-1.24	Upgrade
Other Unusual Items	-	-	-	-	0.17	Upgrade
Pretax Income	-7.51	-8.75	-10.18	-8.62	-5.05	Upgrade
Earnings From Continuing Operations	-7.51	-8.75	-10.18	-8.62	-5.05	Upgrade
Net Income to Company	-7.51	-8.75	-10.18	-8.62	-5.05	Upgrade
Net Income	-7.51	-8.75	-10.18	-8.62	-5.05	Upgrade
Net Income to Common	-7.51	-8.75	-10.18	-8.62	-5.05	Upgrade
Shares Outstanding (Basic)	1,097	941	711	550	331	Upgrade
Shares Outstanding (Diluted)	1,097	941	711	550	331	Upgrade
Shares Change (YoY)	16.55%	32.32%	29.45%	66.10%	132.61%	Upgrade
EPS (Basic)	-0.01	-0.01	-0.01	-0.02	-0.02	Upgrade
EPS (Diluted)	-0.01	-0.01	-0.01	-0.02	-0.02	Upgrade
Free Cash Flow	-7.34	-7.04	-6.4	-6.3	-3.71	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.01	Upgrade
Gross Margin	100.00%	100.00%	86.01%	30.00%	75.29%	Upgrade
Operating Margin	-229.61%	-454.69%	-593.40%	-2568.01%	-399.66%	Upgrade
Profit Margin	-218.28%	-448.03%	-699.91%	-2914.23%	-509.99%	Upgrade
Free Cash Flow Margin	-213.45%	-360.80%	-439.99%	-2130.85%	-374.92%	Upgrade
EBITDA	-7.79	-8.83	-8.53	-7.46	-3.82	Upgrade
EBITDA Margin	-226.49%	-	-	-	-	Upgrade
D&A For EBITDA	0.11	0.04	0.1	0.14	0.14	Upgrade
EBIT	-7.9	-8.88	-8.63	-7.6	-3.96	Upgrade
EBIT Margin	-229.61%	-	-	-	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.